Omeros Corporation (OMER): Price and Financial Metrics

Omeros Corporation (OMER): $2.55

0.01 (+0.39%)

POWR Rating

Component Grades








Add OMER to Watchlist
Sign Up

Industry: Biotech




#156 of 346

in industry

OMER Price/Volume Stats

Current price $2.55 52-week high $7.80
Prev. close $2.54 52-week low $0.92
Day low $2.28 Volume 913,500
Day high $2.62 Avg. volume 716,072
50-day MA $1.87 Dividend yield N/A
200-day MA $4.04 Market Cap 160.31M

OMER Stock Price Chart Interactive Chart >

Omeros Corporation (OMER) Company Bio

Omeros Corporation is a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded in 1994 and is based in Seattle, Washington.

OMER Latest News Stream

Event/Time News Detail
Loading, please wait...

OMER Latest Social Stream

Loading social stream, please wait...

View Full OMER Social Stream

Latest OMER News From Around the Web

Below are the latest news stories about OMEROS CORP that investors may wish to consider to help them evaluate OMER as an investment opportunity.

Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript

Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. At this time, all participants are in a listen-only mode. After the company’s remarks, we will conduct a question-and-answer session. And please be advised that this call is being recorded at the […]

Yahoo | November 11, 2023

Q3 2023 Omeros Corp Earnings Call

Q3 2023 Omeros Corp Earnings Call

Yahoo | November 10, 2023

Omeros Corporation Reports Third Quarter 2023 Financial Results

SEATTLE, November 09, 2023--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2023, which in

Yahoo | November 9, 2023

Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023

SEATTLE, November 06, 2023--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended September 30, 2023, on Thursday, November 9, 2023, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.

Yahoo | November 6, 2023

Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

SEATTLE, November 03, 2023--Omeros Corporation (Nasdaq: OMER) today announced online publication of a report detailing treatment with narsoplimab of 15 adult and pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA), 14 of whom had "high-risk" TA-TMA. Narsoplimab is Omeros’ investigational antibody targeting MASP-2, the effector enzyme of the lectin pathway of the complement system. The report was authored by an external group of investigators

Yahoo | November 3, 2023

Read More 'OMER' Stories Here

OMER Price Returns

1-mo 87.50%
3-mo -24.89%
6-mo -66.00%
1-year 25.00%
3-year -81.90%
5-year -81.81%
YTD 12.83%
2022 -64.85%
2021 -54.99%
2020 1.38%
2019 26.48%
2018 -42.67%

Continue Researching OMER

Want to see what other sources are saying about Omeros Corp's financials and stock price? Try the links below:

Omeros Corp (OMER) Stock Price | Nasdaq
Omeros Corp (OMER) Stock Quote, History and News - Yahoo Finance
Omeros Corp (OMER) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!